-
1
-
-
33746080426
-
Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics
-
Lemay D.G., and Hwang D.H. Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics. J Lipid Res 47 7 (2006) 1583-1587
-
(2006)
J Lipid Res
, vol.47
, Issue.7
, pp. 1583-1587
-
-
Lemay, D.G.1
Hwang, D.H.2
-
2
-
-
16344389190
-
Angiogenesis: where do we stand now?
-
Simons M. Angiogenesis: where do we stand now?. Circulation 111 12 (2005) 1556-1566
-
(2005)
Circulation
, vol.111
, Issue.12
, pp. 1556-1566
-
-
Simons, M.1
-
3
-
-
11144310564
-
An overview on biological mechanisms of PPARs
-
Kota B.P., Huang T.H., and Roufogalis B.D. An overview on biological mechanisms of PPARs. Pharmacol Res 51 2 (2005) 85-94
-
(2005)
Pharmacol Res
, vol.51
, Issue.2
, pp. 85-94
-
-
Kota, B.P.1
Huang, T.H.2
Roufogalis, B.D.3
-
4
-
-
0036183630
-
The mechanisms of action of PPARs
-
Berger J., and Moller D.E. The mechanisms of action of PPARs. Annu Rev Med 53 (2002) 409-435
-
(2002)
Annu Rev Med
, vol.53
, pp. 409-435
-
-
Berger, J.1
Moller, D.E.2
-
5
-
-
0031788318
-
Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development
-
Braissant O., and Wahli W. Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology 139 6 (1998) 2748-2754
-
(1998)
Endocrinology
, vol.139
, Issue.6
, pp. 2748-2754
-
-
Braissant, O.1
Wahli, W.2
-
6
-
-
0030747895
-
Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients
-
Auboeuf D., Rieusset J., Fajas L., Vallier P., Frering V., Riou J.P., et al. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 46 8 (1997) 1319-1327
-
(1997)
Diabetes
, vol.46
, Issue.8
, pp. 1319-1327
-
-
Auboeuf, D.1
Rieusset, J.2
Fajas, L.3
Vallier, P.4
Frering, V.5
Riou, J.P.6
-
7
-
-
0032475922
-
Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages
-
Chinetti G., Griglio S., Antonucci M., Torra I.P., Delerive P., Majd Z., et al. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273 40 (1998) 25573-25580
-
(1998)
J Biol Chem
, vol.273
, Issue.40
, pp. 25573-25580
-
-
Chinetti, G.1
Griglio, S.2
Antonucci, M.3
Torra, I.P.4
Delerive, P.5
Majd, Z.6
-
8
-
-
0032546485
-
Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells
-
Inoue I., Shino K., Noji S., Awata T., and Katayama S. Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells. Biochem Biophys Res Commun 246 2 (1998) 370-374
-
(1998)
Biochem Biophys Res Commun
, vol.246
, Issue.2
, pp. 370-374
-
-
Inoue, I.1
Shino, K.2
Noji, S.3
Awata, T.4
Katayama, S.5
-
9
-
-
0032565868
-
Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators
-
Staels B., Koenig W., Habib A., Merval R., Lebret M., Torra I.P., et al. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 393 6687 (1998) 790-793
-
(1998)
Nature
, vol.393
, Issue.6687
, pp. 790-793
-
-
Staels, B.1
Koenig, W.2
Habib, A.3
Merval, R.4
Lebret, M.5
Torra, I.P.6
-
10
-
-
0030835678
-
The organization, promoter analysis, and expression of the human PPARgamma gene
-
Fajas L., Auboeuf D., Raspe E., Schoonjans K., Lefebvre A.M., Saladin R., et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem 272 30 (1997) 18779-18789
-
(1997)
J Biol Chem
, vol.272
, Issue.30
, pp. 18779-18789
-
-
Fajas, L.1
Auboeuf, D.2
Raspe, E.3
Schoonjans, K.4
Lefebvre, A.M.5
Saladin, R.6
-
11
-
-
0029152375
-
Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping
-
Greene M.E., Blumberg B., McBride O.W., Yi H.F., Kronquist K., Kwan K., et al. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr 4 4-5 (1995) 281-299
-
(1995)
Gene Expr
, vol.4
, Issue.4-5
, pp. 281-299
-
-
Greene, M.E.1
Blumberg, B.2
McBride, O.W.3
Yi, H.F.4
Kronquist, K.5
Kwan, K.6
-
12
-
-
0029102676
-
Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms
-
Zhu Y., Qi C., Korenberg J.R., Chen X.N., Noya D., Rao M.S., et al. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc Natl Acad Sci U S A 92 17 (1995) 7921-7925
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, Issue.17
, pp. 7921-7925
-
-
Zhu, Y.1
Qi, C.2
Korenberg, J.R.3
Chen, X.N.4
Noya, D.5
Rao, M.S.6
-
13
-
-
0030590074
-
Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2
-
Elbrecht A., Chen Y., Cullinan C.A., Hayes N., Leibowitz M., Moller D.E., et al. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem Biophys Res Commun 224 2 (1996) 431-437
-
(1996)
Biochem Biophys Res Commun
, vol.224
, Issue.2
, pp. 431-437
-
-
Elbrecht, A.1
Chen, Y.2
Cullinan, C.A.3
Hayes, N.4
Leibowitz, M.5
Moller, D.E.6
-
14
-
-
0028321529
-
Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
-
Kliewer S.A., Forman B.M., Blumberg B., Ong E.S., Borgmeyer U., Mangelsdorf D.J., et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A 91 15 (1994) 7355-7359
-
(1994)
Proc Natl Acad Sci U S A
, vol.91
, Issue.15
, pp. 7355-7359
-
-
Kliewer, S.A.1
Forman, B.M.2
Blumberg, B.3
Ong, E.S.4
Borgmeyer, U.5
Mangelsdorf, D.J.6
-
15
-
-
0027959552
-
Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators
-
Mukherjee R., Jow L., Noonan D., and McDonnell D.P. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators. J Steroid Biochem Mol Biol 51 3-4 (1994) 157-166
-
(1994)
J Steroid Biochem Mol Biol
, vol.51
, Issue.3-4
, pp. 157-166
-
-
Mukherjee, R.1
Jow, L.2
Noonan, D.3
McDonnell, D.P.4
-
16
-
-
0030218034
-
Assignment of the human nuclear hormone receptor, NUC1 (PPARD), to chromosome 6p21.1-p21.2
-
Yoshikawa T., Brkanac Z., Dupont B.R., Xing G.Q., Leach R.J., and Detera-Wadleigh S.D. Assignment of the human nuclear hormone receptor, NUC1 (PPARD), to chromosome 6p21.1-p21.2. Genomics 35 3 (1996) 637-638
-
(1996)
Genomics
, vol.35
, Issue.3
, pp. 637-638
-
-
Yoshikawa, T.1
Brkanac, Z.2
Dupont, B.R.3
Xing, G.Q.4
Leach, R.J.5
Detera-Wadleigh, S.D.6
-
17
-
-
0028865305
-
Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes
-
Jones P.S., Savory R., Barratt P., Bell A.R., Gray T.J., Jenkins N.A., et al. Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes. Eur J Biochem 233 1 (1995) 219-226
-
(1995)
Eur J Biochem
, vol.233
, Issue.1
, pp. 219-226
-
-
Jones, P.S.1
Savory, R.2
Barratt, P.3
Bell, A.R.4
Gray, T.J.5
Jenkins, N.A.6
-
18
-
-
0028909362
-
Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors
-
Amri E.Z., Bonino F., Ailhaud G., Abumrad N.A., and Grimaldi P.A. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem 270 5 (1995) 2367-2371
-
(1995)
J Biol Chem
, vol.270
, Issue.5
, pp. 2367-2371
-
-
Amri, E.Z.1
Bonino, F.2
Ailhaud, G.3
Abumrad, N.A.4
Grimaldi, P.A.5
-
19
-
-
0033105510
-
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
-
Xu H.E., Lambert M.H., Montana V.G., Parks D.J., Blanchard S.G., Brown P.J., et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3 3 (1999) 397-403
-
(1999)
Mol Cell
, vol.3
, Issue.3
, pp. 397-403
-
-
Xu, H.E.1
Lambert, M.H.2
Montana, V.G.3
Parks, D.J.4
Blanchard, S.G.5
Brown, P.J.6
-
20
-
-
0028972025
-
15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
-
Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., and Evans R.M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83 5 (1995) 803-812
-
(1995)
Cell
, vol.83
, Issue.5
, pp. 803-812
-
-
Forman, B.M.1
Tontonoz, P.2
Chen, J.3
Brun, R.P.4
Spiegelman, B.M.5
Evans, R.M.6
-
21
-
-
0035844217
-
Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists
-
Davies S.S., Pontsler A.V., Marathe G.K., Harrison K.A., Murphy R.C., Hinshaw J.C., et al. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J Biol Chem 276 19 (2001) 16015-16023
-
(2001)
J Biol Chem
, vol.276
, Issue.19
, pp. 16015-16023
-
-
Davies, S.S.1
Pontsler, A.V.2
Marathe, G.K.3
Harrison, K.A.4
Murphy, R.C.5
Hinshaw, J.C.6
-
22
-
-
0030952937
-
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
-
Forman B.M., Chen J., and Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U S A 94 9 (1997) 4312-4317
-
(1997)
Proc Natl Acad Sci U S A
, vol.94
, Issue.9
, pp. 4312-4317
-
-
Forman, B.M.1
Chen, J.2
Evans, R.M.3
-
23
-
-
0028802627
-
Differential activation of peroxisome proliferator-activated receptors by eicosanoids
-
Yu K., Bayona W., Kallen C.B., Harding H.P., Ravera C.P., McMahon G., et al. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 270 41 (1995) 23975-23983
-
(1995)
J Biol Chem
, vol.270
, Issue.41
, pp. 23975-23983
-
-
Yu, K.1
Bayona, W.2
Kallen, C.B.3
Harding, H.P.4
Ravera, C.P.5
McMahon, G.6
-
24
-
-
0013854955
-
Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat
-
Hess R., Staubli W., and Riess W. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature 208 5013 (1965) 856-858
-
(1965)
Nature
, vol.208
, Issue.5013
, pp. 856-858
-
-
Hess, R.1
Staubli, W.2
Riess, W.3
-
25
-
-
0032506273
-
Mechanism of action of fibrates on lipid and lipoprotein metabolism
-
Staels B., Dallongeville J., Auwerx J., Schoonjans K., Leitersdorf E., and Fruchart J.C. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98 19 (1998) 2088-2093
-
(1998)
Circulation
, vol.98
, Issue.19
, pp. 2088-2093
-
-
Staels, B.1
Dallongeville, J.2
Auwerx, J.3
Schoonjans, K.4
Leitersdorf, E.5
Fruchart, J.C.6
-
26
-
-
0033998334
-
The PPARs: from orphan receptors to drug discovery
-
Willson T.M., Brown P.J., Sternbach D.D., and Henke B.R. The PPARs: from orphan receptors to drug discovery. J Med Chem 43 4 (2000) 527-550
-
(2000)
J Med Chem
, vol.43
, Issue.4
, pp. 527-550
-
-
Willson, T.M.1
Brown, P.J.2
Sternbach, D.D.3
Henke, B.R.4
-
27
-
-
0029745382
-
Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice
-
Berger J., Bailey P., Biswas C., Cullinan C.A., Doebber T.W., Hayes N.S., et al. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137 10 (1996) 4189-4195
-
(1996)
Endocrinology
, vol.137
, Issue.10
, pp. 4189-4195
-
-
Berger, J.1
Bailey, P.2
Biswas, C.3
Cullinan, C.A.4
Doebber, T.W.5
Hayes, N.S.6
-
28
-
-
0031013395
-
Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs
-
Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., and Kliewer S.A. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272 6 (1997) 3406-3410
-
(1997)
J Biol Chem
, vol.272
, Issue.6
, pp. 3406-3410
-
-
Lehmann, J.M.1
Lenhard, J.M.2
Oliver, B.B.3
Ringold, G.M.4
Kliewer, S.A.5
-
29
-
-
0034685589
-
Activation of PPARdelta alters lipid metabolism in db/db mice
-
Leibowitz M.D., Fievet C., Hennuyer N., Peinado-Onsurbe J., Duez H., Bergera J., et al. Activation of PPARdelta alters lipid metabolism in db/db mice. FEBS Lett 473 3 (2000) 333-336
-
(2000)
FEBS Lett
, vol.473
, Issue.3
, pp. 333-336
-
-
Leibowitz, M.D.1
Fievet, C.2
Hennuyer, N.3
Peinado-Onsurbe, J.4
Duez, H.5
Bergera, J.6
-
30
-
-
0035942162
-
A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport
-
Oliver Jr. W.R., Shenk J.L., Snaith M.R., Russell C.S., Plunket K.D., Bodkin N.L., et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A 98 9 (2001) 5306-5311
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, Issue.9
, pp. 5306-5311
-
-
Oliver Jr., W.R.1
Shenk, J.L.2
Snaith, M.R.3
Russell, C.S.4
Plunket, K.D.5
Bodkin, N.L.6
-
31
-
-
2442671417
-
Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)
-
Tenenbaum A., Fisman E.Z., and Motro M. Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR). Cardiovasc Diabetol 2 (2003) 4
-
(2003)
Cardiovasc Diabetol
, vol.2
, pp. 4
-
-
Tenenbaum, A.1
Fisman, E.Z.2
Motro, M.3
-
32
-
-
0035993444
-
Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis
-
Vosper H., Khoudoli G.A., Graham T.L., and Palmer C.N. Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis. Pharmacol Ther 95 1 (2002) 47-62
-
(2002)
Pharmacol Ther
, vol.95
, Issue.1
, pp. 47-62
-
-
Vosper, H.1
Khoudoli, G.A.2
Graham, T.L.3
Palmer, C.N.4
-
34
-
-
33750404258
-
Thiazolidinediones and risk for atherosclerosis: pleiotropic effects of PPar gamma agonism
-
Patel C.B., De Lemos J.A., Wyne K.L., and McGuire D.K. Thiazolidinediones and risk for atherosclerosis: pleiotropic effects of PPar gamma agonism. Diab Vasc Dis Res 3 2 (2006) 65-71
-
(2006)
Diab Vasc Dis Res
, vol.3
, Issue.2
, pp. 65-71
-
-
Patel, C.B.1
De Lemos, J.A.2
Wyne, K.L.3
McGuire, D.K.4
-
35
-
-
0037699955
-
Angiogenesis in health and disease
-
Carmeliet P. Angiogenesis in health and disease. Nat Med 9 6 (2003) 653-660
-
(2003)
Nat Med
, vol.9
, Issue.6
, pp. 653-660
-
-
Carmeliet, P.1
-
36
-
-
0038037735
-
Regulation of angiogenesis by hypoxia: role of the HIF system
-
Pugh C.W., and Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9 6 (2003) 677-684
-
(2003)
Nat Med
, vol.9
, Issue.6
, pp. 677-684
-
-
Pugh, C.W.1
Ratcliffe, P.J.2
-
37
-
-
0034094342
-
The pathophysiology of the collateral circulation (arteriogenesis)
-
Buschmann I., and Schaper W. The pathophysiology of the collateral circulation (arteriogenesis). J Pathol 190 3 (2000) 338-342
-
(2000)
J Pathol
, vol.190
, Issue.3
, pp. 338-342
-
-
Buschmann, I.1
Schaper, W.2
-
38
-
-
8344237449
-
Hydroxylation of HIF-1: oxygen sensing at the molecular level
-
Semenza G.L. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19 (2004) 176-182
-
(2004)
Physiology (Bethesda)
, vol.19
, pp. 176-182
-
-
Semenza, G.L.1
-
39
-
-
0343920277
-
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
-
Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 6573 (1996) 435-439
-
(1996)
Nature
, vol.380
, Issue.6573
, pp. 435-439
-
-
Carmeliet, P.1
Ferreira, V.2
Breier, G.3
Pollefeyt, S.4
Kieckens, L.5
Gertsenstein, M.6
-
40
-
-
9244227572
-
Vascular endothelial growth factor B, a novel growth factor for endothelial cells
-
Olofsson B., Pajusola K., Kaipainen A., von Euler G., Joukov V., Saksela O., et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A 93 6 (1996) 2576-2581
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, Issue.6
, pp. 2576-2581
-
-
Olofsson, B.1
Pajusola, K.2
Kaipainen, A.3
von Euler, G.4
Joukov, V.5
Saksela, O.6
-
41
-
-
0030026897
-
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
-
Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15 2 (1996) 290-298
-
(1996)
EMBO J
, vol.15
, Issue.2
, pp. 290-298
-
-
Joukov, V.1
Pajusola, K.2
Kaipainen, A.3
Chilov, D.4
Lahtinen, I.5
Kukk, E.6
-
42
-
-
0035126049
-
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
-
Stacker S.A., Caesar C., Baldwin M.E., Thornton G.E., Williams R.A., Prevo R., et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7 2 (2001) 186-191
-
(2001)
Nat Med
, vol.7
, Issue.2
, pp. 186-191
-
-
Stacker, S.A.1
Caesar, C.2
Baldwin, M.E.3
Thornton, G.E.4
Williams, R.A.5
Prevo, R.6
-
43
-
-
17744396472
-
Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
-
Veikkola T., Jussila L., Makinen T., Karpanen T., Jeltsch M., Petrova T.V., et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20 6 (2001) 1223-1231
-
(2001)
EMBO J
, vol.20
, Issue.6
, pp. 1223-1231
-
-
Veikkola, T.1
Jussila, L.2
Makinen, T.3
Karpanen, T.4
Jeltsch, M.5
Petrova, T.V.6
-
44
-
-
17044384530
-
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis
-
Lim H.S., Lip G.Y., and Blann A.D. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. Atherosclerosis 180 1 (2005) 113-118
-
(2005)
Atherosclerosis
, vol.180
, Issue.1
, pp. 113-118
-
-
Lim, H.S.1
Lip, G.Y.2
Blann, A.D.3
-
45
-
-
0034979273
-
Role of vascular endothelial growth factor in regulation of physiological angiogenesis
-
Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280 6 (2001) C1358-C1366
-
(2001)
Am J Physiol Cell Physiol
, vol.280
, Issue.6
-
-
Ferrara, N.1
-
46
-
-
0030460424
-
Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
-
Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87 7 (1996) 1161-1169
-
(1996)
Cell
, vol.87
, Issue.7
, pp. 1161-1169
-
-
Davis, S.1
Aldrich, T.H.2
Jones, P.F.3
Acheson, A.4
Compton, D.L.5
Jain, V.6
-
47
-
-
0344450778
-
Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
-
Papapetropoulos A., Garcia-Cardena G., Dengler T.J., Maisonpierre P.C., Yancopoulos G.D., and Sessa W.C. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest 79 2 (1999) 213-223
-
(1999)
Lab Invest
, vol.79
, Issue.2
, pp. 213-223
-
-
Papapetropoulos, A.1
Garcia-Cardena, G.2
Dengler, T.J.3
Maisonpierre, P.C.4
Yancopoulos, G.D.5
Sessa, W.C.6
-
48
-
-
15144358851
-
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
-
Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 5322 (1997) 55-60
-
(1997)
Science
, vol.277
, Issue.5322
, pp. 55-60
-
-
Maisonpierre, P.C.1
Suri, C.2
Jones, P.F.3
Bartunkova, S.4
Wiegand, S.J.5
Radziejewski, C.6
-
49
-
-
0037143737
-
Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo
-
Lobov I.B., Brooks P.C., and Lang R.A. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A 99 17 (2002) 11205-11210
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, Issue.17
, pp. 11205-11210
-
-
Lobov, I.B.1
Brooks, P.C.2
Lang, R.A.3
-
50
-
-
0035348182
-
Plaque angiogenesis and atherosclerosis
-
Moulton K.S. Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep 3 3 (2001) 225-233
-
(2001)
Curr Atheroscler Rep
, vol.3
, Issue.3
, pp. 225-233
-
-
Moulton, K.S.1
-
51
-
-
0037372172
-
Abnormal angiogenesis in diabetes mellitus
-
Martin A., Komada M.R., and Sane D.C. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 23 2 (2003) 117-145
-
(2003)
Med Res Rev
, vol.23
, Issue.2
, pp. 117-145
-
-
Martin, A.1
Komada, M.R.2
Sane, D.C.3
-
52
-
-
33646883882
-
Clinical and experimental studies on role of oxygen in retrolental fibroplasia
-
Patz A. Clinical and experimental studies on role of oxygen in retrolental fibroplasia. Trans Am Acad Ophthalmol Otolaryngol 58 1 (1954) 45-50
-
(1954)
Trans Am Acad Ophthalmol Otolaryngol
, vol.58
, Issue.1
, pp. 45-50
-
-
Patz, A.1
-
53
-
-
0033939404
-
Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment
-
Lip P.L., Belgore F., Blann A.D., Hope-Ross M.W., Gibson J.M., and Lip G.Y. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. Invest Ophthalmol Vis Sci 41 8 (2000) 2115-2119
-
(2000)
Invest Ophthalmol Vis Sci
, vol.41
, Issue.8
, pp. 2115-2119
-
-
Lip, P.L.1
Belgore, F.2
Blann, A.D.3
Hope-Ross, M.W.4
Gibson, J.M.5
Lip, G.Y.6
-
54
-
-
0027408091
-
The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes
-
Nyengaard J.R., and Rasch R. The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia 36 3 (1993) 189-194
-
(1993)
Diabetologia
, vol.36
, Issue.3
, pp. 189-194
-
-
Nyengaard, J.R.1
Rasch, R.2
-
55
-
-
0031738762
-
Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds
-
Loots M.A., Lamme E.N., Zeegelaar J., Mekkes J.R., Bos J.D., and Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 111 5 (1998) 850-857
-
(1998)
J Invest Dermatol
, vol.111
, Issue.5
, pp. 850-857
-
-
Loots, M.A.1
Lamme, E.N.2
Zeegelaar, J.3
Mekkes, J.R.4
Bos, J.D.5
Middelkoop, E.6
-
56
-
-
0030059386
-
The histology of diabetic foot ulcers
-
Ferguson M.W., Herrick S.E., Spencer M.J., Shaw J.E., Boulton A.J., and Sloan P. The histology of diabetic foot ulcers. Diabet Med 13 Suppl. 1 (1996) S30-S33
-
(1996)
Diabet Med
, vol.13
, Issue.SUPPL. 1
-
-
Ferguson, M.W.1
Herrick, S.E.2
Spencer, M.J.3
Shaw, J.E.4
Boulton, A.J.5
Sloan, P.6
-
57
-
-
0035895708
-
Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications
-
Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 49 3 (2001) 554-560
-
(2001)
Cardiovasc Res
, vol.49
, Issue.3
, pp. 554-560
-
-
Waltenberger, J.1
-
58
-
-
0027934755
-
Coronary artery disease and coronary artery bypass grafting in diabetic patients aged > or = 65 years (report from the Coronary Artery Surgery Study [CASS] Registry)
-
Barzilay J.I., Kronmal R.A., Bittner V., Eaker E., Evans C., and Foster E.D. Coronary artery disease and coronary artery bypass grafting in diabetic patients aged > or = 65 years (report from the Coronary Artery Surgery Study [CASS] Registry). Am J Cardiol 74 4 (1994) 334-339
-
(1994)
Am J Cardiol
, vol.74
, Issue.4
, pp. 334-339
-
-
Barzilay, J.I.1
Kronmal, R.A.2
Bittner, V.3
Eaker, E.4
Evans, C.5
Foster, E.D.6
-
59
-
-
0026598279
-
Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material
-
Yarom R., Zirkin H., Stammler G., and Rose A.G. Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material. J Pathol 166 3 (1992) 265-270
-
(1992)
J Pathol
, vol.166
, Issue.3
, pp. 265-270
-
-
Yarom, R.1
Zirkin, H.2
Stammler, G.3
Rose, A.G.4
-
60
-
-
0032965317
-
Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF
-
Rivard A., Silver M., Chen D., Kearney M., Magner M., Annex B., et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154 2 (1999) 355-363
-
(1999)
Am J Pathol
, vol.154
, Issue.2
, pp. 355-363
-
-
Rivard, A.1
Silver, M.2
Chen, D.3
Kearney, M.4
Magner, M.5
Annex, B.6
-
61
-
-
0029973366
-
Distribution of systemically administered ampicillin, benzylpenicillin, and flucloxacillin in excisional wounds in diabetic and normal rats and effects of local topical vasodilator treatment
-
Cross S.E., Thompson M.J., and Roberts M.S. Distribution of systemically administered ampicillin, benzylpenicillin, and flucloxacillin in excisional wounds in diabetic and normal rats and effects of local topical vasodilator treatment. Antimicrob Agents Chemother 40 7 (1996) 1703-1710
-
(1996)
Antimicrob Agents Chemother
, vol.40
, Issue.7
, pp. 1703-1710
-
-
Cross, S.E.1
Thompson, M.J.2
Roberts, M.S.3
-
62
-
-
0027385107
-
Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function
-
Maxfield E.K., Cameron N.E., Cotter M.A., and Dines K.C. Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function. Diabetologia 36 12 (1993) 1230-1237
-
(1993)
Diabetologia
, vol.36
, Issue.12
, pp. 1230-1237
-
-
Maxfield, E.K.1
Cameron, N.E.2
Cotter, M.A.3
Dines, K.C.4
-
63
-
-
0034038502
-
Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy
-
Stevens M.J., Obrosova I., Cao X., Van Huysen C., and Greene D.A. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49 6 (2000) 1006-1015
-
(2000)
Diabetes
, vol.49
, Issue.6
, pp. 1006-1015
-
-
Stevens, M.J.1
Obrosova, I.2
Cao, X.3
Van Huysen, C.4
Greene, D.A.5
-
64
-
-
0030774675
-
Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark
-
Wideroff L., Gridley G., Mellemkjaer L., Chow W.H., Linet M., Keehn S., et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89 18 (1997) 1360-1365
-
(1997)
J Natl Cancer Inst
, vol.89
, Issue.18
, pp. 1360-1365
-
-
Wideroff, L.1
Gridley, G.2
Mellemkjaer, L.3
Chow, W.H.4
Linet, M.5
Keehn, S.6
-
65
-
-
0027942607
-
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
-
Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331 22 (1994) 1480-1487
-
(1994)
N Engl J Med
, vol.331
, Issue.22
, pp. 1480-1487
-
-
Aiello, L.P.1
Avery, R.L.2
Arrigg, P.G.3
Keyt, B.A.4
Jampel, H.D.5
Shah, S.T.6
-
66
-
-
0033007062
-
Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195
-
Tsuchida K., Makita Z., Yamagishi S., Atsumi T., Miyoshi H., Obara S., et al. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 42 5 (1999) 579-588
-
(1999)
Diabetologia
, vol.42
, Issue.5
, pp. 579-588
-
-
Tsuchida, K.1
Makita, Z.2
Yamagishi, S.3
Atsumi, T.4
Miyoshi, H.5
Obara, S.6
-
67
-
-
0035085050
-
Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair
-
Kampfer H., Pfeilschifter J., and Frank S. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest 81 3 (2001) 361-373
-
(2001)
Lab Invest
, vol.81
, Issue.3
, pp. 361-373
-
-
Kampfer, H.1
Pfeilschifter, J.2
Frank, S.3
-
68
-
-
0242322346
-
Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia
-
Boger R.H., Bode-Boger S.M., Szuba A., Tsao P.S., Chan J.R., Tangphao O., et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98 18 (1998) 1842-1847
-
(1998)
Circulation
, vol.98
, Issue.18
, pp. 1842-1847
-
-
Boger, R.H.1
Bode-Boger, S.M.2
Szuba, A.3
Tsao, P.S.4
Chan, J.R.5
Tangphao, O.6
-
69
-
-
0027141119
-
Vasodilation of rat retinal microvessels induced by monobutyrin. Dysregulation in diabetes
-
Halvorsen Y.D., Bursell S.E., Wilkison W.O., Clermont A.C., Brittis M., McGovern T.J., et al. Vasodilation of rat retinal microvessels induced by monobutyrin. Dysregulation in diabetes. J Clin Invest 92 6 (1993) 2872-2876
-
(1993)
J Clin Invest
, vol.92
, Issue.6
, pp. 2872-2876
-
-
Halvorsen, Y.D.1
Bursell, S.E.2
Wilkison, W.O.3
Clermont, A.C.4
Brittis, M.5
McGovern, T.J.6
-
70
-
-
0033605677
-
Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo
-
Xin X., Yang S., Kowalski J., and Gerritsen M.E. Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo. J Biol Chem 274 13 (1999) 9116-9121
-
(1999)
J Biol Chem
, vol.274
, Issue.13
, pp. 9116-9121
-
-
Xin, X.1
Yang, S.2
Kowalski, J.3
Gerritsen, M.E.4
-
71
-
-
0036771776
-
PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis
-
Panigrahy D., Singer S., Shen L.Q., Butterfield C.E., Freedman D.A., Chen E.J., et al. PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J Clin Invest 110 7 (2002) 923-932
-
(2002)
J Clin Invest
, vol.110
, Issue.7
, pp. 923-932
-
-
Panigrahy, D.1
Singer, S.2
Shen, L.Q.3
Butterfield, C.E.4
Freedman, D.A.5
Chen, E.J.6
-
72
-
-
2142701648
-
Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization
-
Murata T., He S., Hangai M., Ishibashi T., Xi X.P., Kim S., et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. Invest Ophthalmol Vis Sci 41 8 (2000) 2309-2317
-
(2000)
Invest Ophthalmol Vis Sci
, vol.41
, Issue.8
, pp. 2309-2317
-
-
Murata, T.1
He, S.2
Hangai, M.3
Ishibashi, T.4
Xi, X.P.5
Kim, S.6
-
73
-
-
33644609473
-
PPARgamma represses VEGF expression in human endometrial cells: implications for uterine angiogenesis
-
Peeters L.L., Vigne J.L., Tee M.K., Zhao D., Waite L.L., and Taylor R.N. PPARgamma represses VEGF expression in human endometrial cells: implications for uterine angiogenesis. Angiogenesis 8 4 (2005) 373-379
-
(2005)
Angiogenesis
, vol.8
, Issue.4
, pp. 373-379
-
-
Peeters, L.L.1
Vigne, J.L.2
Tee, M.K.3
Zhao, D.4
Waite, L.L.5
Taylor, R.N.6
-
74
-
-
33745424209
-
Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia
-
Chu K., Lee S.T., Koo J.S., Jung K.H., Kim E.H., Sinn D.I., et al. Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia. Brain Res 1093 1 (2006) 208-218
-
(2006)
Brain Res
, vol.1093
, Issue.1
, pp. 208-218
-
-
Chu, K.1
Lee, S.T.2
Koo, J.S.3
Jung, K.H.4
Kim, E.H.5
Sinn, D.I.6
-
75
-
-
0034685660
-
Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells
-
Yamakawa K., Hosoi M., Koyama H., Tanaka S., Fukumoto S., Morii H., et al. Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells. Biochem Biophys Res Commun 271 3 (2000) 571-574
-
(2000)
Biochem Biophys Res Commun
, vol.271
, Issue.3
, pp. 571-574
-
-
Yamakawa, K.1
Hosoi, M.2
Koyama, H.3
Tanaka, S.4
Fukumoto, S.5
Morii, H.6
-
76
-
-
0034585795
-
Ligands of peroxisome proliferator-activated receptor-gamma increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages
-
Jozkowicz A., Dulak J., Piatkowska E., Placha W., and Dembinska-Kiec A. Ligands of peroxisome proliferator-activated receptor-gamma increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages. Acta Biochim Pol 47 4 (2000) 1147-1157
-
(2000)
Acta Biochim Pol
, vol.47
, Issue.4
, pp. 1147-1157
-
-
Jozkowicz, A.1
Dulak, J.2
Piatkowska, E.3
Placha, W.4
Dembinska-Kiec, A.5
-
77
-
-
26244433267
-
PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells
-
Pistrosch F., Herbrig K., Oelschlaegel U., Richter S., Passauer J., Fischer S., et al. PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis 183 1 (2005) 163-167
-
(2005)
Atherosclerosis
, vol.183
, Issue.1
, pp. 163-167
-
-
Pistrosch, F.1
Herbrig, K.2
Oelschlaegel, U.3
Richter, S.4
Passauer, J.5
Fischer, S.6
-
78
-
-
33847674375
-
PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts
-
Chintalgattu V., Harris G.S., Akula S.M., and Katwa L.C. PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts. Cardiovasc Res 74 1 (2007) 140-150
-
(2007)
Cardiovasc Res
, vol.74
, Issue.1
, pp. 140-150
-
-
Chintalgattu, V.1
Harris, G.S.2
Akula, S.M.3
Katwa, L.C.4
-
79
-
-
22144441406
-
Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation
-
Liu H.B., Hu Y.S., Medcalf R.L., Simpson R.W., and Dear A.E. Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation. Biochem Biophys Res Commun 334 1 (2005) 30-37
-
(2005)
Biochem Biophys Res Commun
, vol.334
, Issue.1
, pp. 30-37
-
-
Liu, H.B.1
Hu, Y.S.2
Medcalf, R.L.3
Simpson, R.W.4
Dear, A.E.5
-
80
-
-
33947314469
-
Troglitazone and pioglitazone interactions via PPAR-gamma-independent and -dependent pathways in regulating physiological responses in renal tubule-derived cell lines
-
Turturro F., Oliver III R., Friday E., Nissim I., and Welbourne T. Troglitazone and pioglitazone interactions via PPAR-gamma-independent and -dependent pathways in regulating physiological responses in renal tubule-derived cell lines. Am J Physiol Cell Physiol 292 3 (2007) C1137-C1146
-
(2007)
Am J Physiol Cell Physiol
, vol.292
, Issue.3
-
-
Turturro, F.1
Oliver III, R.2
Friday, E.3
Nissim, I.4
Welbourne, T.5
-
81
-
-
13944280963
-
Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma
-
Shiau C.W., Yang C.C., Kulp S.K., Chen K.F., Chen C.S., Huang J.W., et al. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma. Cancer Res 65 4 (2005) 1561-1569
-
(2005)
Cancer Res
, vol.65
, Issue.4
, pp. 1561-1569
-
-
Shiau, C.W.1
Yang, C.C.2
Kulp, S.K.3
Chen, K.F.4
Chen, C.S.5
Huang, J.W.6
-
82
-
-
7244234089
-
Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms
-
Galli A., Ceni E., Crabb D.W., Mello T., Salzano R., Grappone C., et al. Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms. Gut 53 11 (2004) 1688-1697
-
(2004)
Gut
, vol.53
, Issue.11
, pp. 1688-1697
-
-
Galli, A.1
Ceni, E.2
Crabb, D.W.3
Mello, T.4
Salzano, R.5
Grappone, C.6
-
83
-
-
15444369845
-
Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress
-
Gardner O.S., Shiau C.W., Chen C.S., and Graves L.M. Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress. J Biol Chem 280 11 (2005) 10109-10118
-
(2005)
J Biol Chem
, vol.280
, Issue.11
, pp. 10109-10118
-
-
Gardner, O.S.1
Shiau, C.W.2
Chen, C.S.3
Graves, L.M.4
-
84
-
-
34247623569
-
Upregulation of VEGF by 15-deoxy-Delta12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells
-
Kim E.H., Na H.K., and Surh Y.J. Upregulation of VEGF by 15-deoxy-Delta12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells. Ann N Y Acad Sci 1090 (2006) 375-384
-
(2006)
Ann N Y Acad Sci
, vol.1090
, pp. 375-384
-
-
Kim, E.H.1
Na, H.K.2
Surh, Y.J.3
-
85
-
-
0028036723
-
Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element
-
Vu-Dac N., Schoonjans K., Laine B., Fruchart J.C., Auwerx J., and Staels B. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J Biol Chem 269 49 (1994) 31012-31018
-
(1994)
J Biol Chem
, vol.269
, Issue.49
, pp. 31012-31018
-
-
Vu-Dac, N.1
Schoonjans, K.2
Laine, B.3
Fruchart, J.C.4
Auwerx, J.5
Staels, B.6
-
86
-
-
0345283278
-
Bezafibrate induces a mitochondrial derangement in human cell lines: a PPAR-independent mechanism for a peroxisome proliferator
-
Scatena R., Bottoni P., Vincenzoni F., Messana I., Martorana G.E., Nocca G., et al. Bezafibrate induces a mitochondrial derangement in human cell lines: a PPAR-independent mechanism for a peroxisome proliferator. Chem Res Toxicol 16 11 (2003) 1440-1447
-
(2003)
Chem Res Toxicol
, vol.16
, Issue.11
, pp. 1440-1447
-
-
Scatena, R.1
Bottoni, P.2
Vincenzoni, F.3
Messana, I.4
Martorana, G.E.5
Nocca, G.6
-
87
-
-
33748762243
-
Fibrates upregulate TRB3 in lymphocytes independent of PPAR alpha by augmenting CCAAT/enhancer-binding protein beta (C/EBP beta) expression
-
Selim E., Frkanec J.T., and Cunard R. Fibrates upregulate TRB3 in lymphocytes independent of PPAR alpha by augmenting CCAAT/enhancer-binding protein beta (C/EBP beta) expression. Mol Immunol 44 6 (2007) 1218-1229
-
(2007)
Mol Immunol
, vol.44
, Issue.6
, pp. 1218-1229
-
-
Selim, E.1
Frkanec, J.T.2
Cunard, R.3
-
88
-
-
33745429839
-
Peroxisome proliferator-activated receptor alpha-independent peroxisome proliferation
-
Zhang X., Tanaka N., Nakajima T., Kamijo Y., Gonzalez F.J., and Aoyama T. Peroxisome proliferator-activated receptor alpha-independent peroxisome proliferation. Biochem Biophys Res Commun 346 4 (2006) 1307-1311
-
(2006)
Biochem Biophys Res Commun
, vol.346
, Issue.4
, pp. 1307-1311
-
-
Zhang, X.1
Tanaka, N.2
Nakajima, T.3
Kamijo, Y.4
Gonzalez, F.J.5
Aoyama, T.6
-
89
-
-
34047243022
-
Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression
-
Wang D., Wang H., Guo Y., Ning W., Katkuri S., Wahli W., et al. Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression. Proc Natl Acad Sci U S A 103 50 (2006) 19069-19074
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, Issue.50
, pp. 19069-19074
-
-
Wang, D.1
Wang, H.2
Guo, Y.3
Ning, W.4
Katkuri, S.5
Wahli, W.6
-
90
-
-
33646269042
-
Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis
-
Marin H.E., Peraza M.A., Billin A.N., Willson T.M., Ward J.M., Kennett M.J., et al. Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis. Cancer Res 66 8 (2006) 4394-4401
-
(2006)
Cancer Res
, vol.66
, Issue.8
, pp. 4394-4401
-
-
Marin, H.E.1
Peraza, M.A.2
Billin, A.N.3
Willson, T.M.4
Ward, J.M.5
Kennett, M.J.6
-
91
-
-
47349117843
-
Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism
-
Biscetti F., Gaetani E., Flex A., Aprahamian T., Hopkins T., Straface G., et al. Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism. Diabetes 57 5 (2008) 1394-1404
-
(2008)
Diabetes
, vol.57
, Issue.5
, pp. 1394-1404
-
-
Biscetti, F.1
Gaetani, E.2
Flex, A.3
Aprahamian, T.4
Hopkins, T.5
Straface, G.6
-
92
-
-
33846577833
-
Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis
-
Piqueras L., Reynolds A.R., Hodivala-Dilke K.M., Alfranca A., Redondo J.M., Hatae T., et al. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis. Arterioscler Thromb Vasc Biol 27 1 (2007) 63-69
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, Issue.1
, pp. 63-69
-
-
Piqueras, L.1
Reynolds, A.R.2
Hodivala-Dilke, K.M.3
Alfranca, A.4
Redondo, J.M.5
Hatae, T.6
-
93
-
-
34548182594
-
PPAR dual agonists: are they opening Pandora's Box?
-
Balakumar P., Rose M., Ganti S.S., Krishan P., and Singh M. PPAR dual agonists: are they opening Pandora's Box?. Pharmacol Res 56 2 (2007) 91-98
-
(2007)
Pharmacol Res
, vol.56
, Issue.2
, pp. 91-98
-
-
Balakumar, P.1
Rose, M.2
Ganti, S.S.3
Krishan, P.4
Singh, M.5
-
94
-
-
34447547870
-
Tesaglitazar, a PPARalpha/gamma agonist, induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats
-
Hellmold H., Zhang H., Andersson U., Blomgren B., Holland T., Berg A.L., et al. Tesaglitazar, a PPARalpha/gamma agonist, induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats. Toxicol Sci 98 1 (2007) 63-74
-
(2007)
Toxicol Sci
, vol.98
, Issue.1
, pp. 63-74
-
-
Hellmold, H.1
Zhang, H.2
Andersson, U.3
Blomgren, B.4
Holland, T.5
Berg, A.L.6
-
95
-
-
33745957332
-
Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study
-
Kendall D.M., Rubin C.J., Mohideen P., Ledeine J.M., Belder R., Gross J., et al. Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study. Diabetes Care 29 5 (2006) 1016-1023
-
(2006)
Diabetes Care
, vol.29
, Issue.5
, pp. 1016-1023
-
-
Kendall, D.M.1
Rubin, C.J.2
Mohideen, P.3
Ledeine, J.M.4
Belder, R.5
Gross, J.6
-
96
-
-
33847166204
-
Increase in weight induced by muraglitazar, a dual PPARalpha/gamma agonist, in db/db mice: adipogenesis/or oedema?
-
Mittra S., Sangle G., Tandon R., Sharma S., Roy S., Khanna V., et al. Increase in weight induced by muraglitazar, a dual PPARalpha/gamma agonist, in db/db mice: adipogenesis/or oedema?. Br J Pharmacol 150 4 (2007) 480-487
-
(2007)
Br J Pharmacol
, vol.150
, Issue.4
, pp. 480-487
-
-
Mittra, S.1
Sangle, G.2
Tandon, R.3
Sharma, S.4
Roy, S.5
Khanna, V.6
-
97
-
-
0842289940
-
In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control
-
Pistrosch F., Passauer J., Fischer S., Fuecker K., Hanefeld M., and Gross P. In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control. Diabetes Care 27 2 (2004) 484-490
-
(2004)
Diabetes Care
, vol.27
, Issue.2
, pp. 484-490
-
-
Pistrosch, F.1
Passauer, J.2
Fischer, S.3
Fuecker, K.4
Hanefeld, M.5
Gross, P.6
-
98
-
-
0027359953
-
Vascular permeability factor (VPF, VEGF) in tumor biology
-
Senger D.R., Van de Water L., Brown L.F., Nagy J.A., Yeo K.T., Yeo T.K., et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12 3-4 (1993) 303-324
-
(1993)
Cancer Metastasis Rev
, vol.12
, Issue.3-4
, pp. 303-324
-
-
Senger, D.R.1
Van de Water, L.2
Brown, L.F.3
Nagy, J.A.4
Yeo, K.T.5
Yeo, T.K.6
-
99
-
-
25444522479
-
Role of angiogenesis in cardiovascular disease: a critical appraisal
-
Khurana R., Simons M., Martin J.F., and Zachary I.C. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 112 12 (2005) 1813-1824
-
(2005)
Circulation
, vol.112
, Issue.12
, pp. 1813-1824
-
-
Khurana, R.1
Simons, M.2
Martin, J.F.3
Zachary, I.C.4
-
100
-
-
34250212715
-
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
-
Nissen S.E., and Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356 24 (2007) 2457-2471
-
(2007)
N Engl J Med
, vol.356
, Issue.24
, pp. 2457-2471
-
-
Nissen, S.E.1
Wolski, K.2
-
101
-
-
33847006914
-
PPAR alpha agonists improve renal preservation in kidneys subjected to chronic in vitro perfusion: interaction with mannitol
-
Jackson T.C., Mi Z., Bastacky S.I., McHale T., Melhem M.F., Sonalker P.A., et al. PPAR alpha agonists improve renal preservation in kidneys subjected to chronic in vitro perfusion: interaction with mannitol. Transpl Int 20 3 (2007) 277-290
-
(2007)
Transpl Int
, vol.20
, Issue.3
, pp. 277-290
-
-
Jackson, T.C.1
Mi, Z.2
Bastacky, S.I.3
McHale, T.4
Melhem, M.F.5
Sonalker, P.A.6
-
102
-
-
2942516599
-
Effect of simvastatin and fenofibrate on endothelium in Type 2 diabetes
-
Skrha J., Stulc T., Hilgertova J., Weiserova H., Kvasnicka J., and Ceska R. Effect of simvastatin and fenofibrate on endothelium in Type 2 diabetes. Eur J Pharmacol 493 1-3 (2004) 183-189
-
(2004)
Eur J Pharmacol
, vol.493
, Issue.1-3
, pp. 183-189
-
-
Skrha, J.1
Stulc, T.2
Hilgertova, J.3
Weiserova, H.4
Kvasnicka, J.5
Ceska, R.6
|